Correlation Between Seer and Acrivon Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Seer and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seer and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Seer Inc and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Seer and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seer with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seer and Acrivon Therapeutics,.

Diversification Opportunities for Seer and Acrivon Therapeutics,

-0.36

Correlation Coefficient

Seer  Acrivon Therapeutics,

Very good diversification

The 3 months correlation between Seer and Acrivon is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Seer Inc and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Seer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seer Inc are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Seer i.e., Seer and Acrivon Therapeutics, go up and down completely randomly.

Pair Corralation between Seer and Acrivon Therapeutics,

Given the investment horizon of 90 days Seer Inc is expected to generate 0.8 times more return on investment than Acrivon Therapeutics,. However, Seer Inc is 1.24 times less risky than Acrivon Therapeutics,. It trades about 0.16 of its potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about 0.0 per unit of risk. If you would invest  177.00  in Seer Inc on September 18, 2024 and sell it today you would earn a total of  57.00  from holding Seer Inc or generate 32.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Seer Inc  vs.  Acrivon Therapeutics, Common

Seer Inc

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Seer Inc are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady technical and fundamental indicators, Seer reported solid returns over the last few months and may actually be approaching a breakup point.

Acrivon Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Acrivon Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Acrivon Therapeutics, is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Seer and Acrivon Therapeutics,

The main advantage of trading using opposite Seer and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seer position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.

The idea behind Seer Inc and Acrivon Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.